Michael King
Stock Analyst at EF Hutton
(0.81)
# 3,752
Out of 4,847 analysts
117
Total ratings
34.15%
Success rate
-16.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael King
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLM Apollomics | Maintains: Buy | $1,100 → $650 | $6.47 | +9,946.37% | 4 | Apr 1, 2024 | |
| SONN Sonnet BioTherapeutics Holdings | Assumes: Buy | $1,179 | $1.17 | +100,936.76% | 7 | Aug 23, 2023 | |
| LTRN Lantern Pharma | Reiterates: Buy | $11 | $3.27 | +236.39% | 10 | Aug 10, 2023 | |
| BMEA Biomea Fusion | Reiterates: Buy | $32 | $2.49 | +1,185.14% | 11 | Jun 26, 2023 | |
| JSPR Jasper Therapeutics | Reiterates: Buy | $69 | $5.90 | +1,061.02% | 10 | Jun 12, 2023 | |
| COEP Coeptis Therapeutics Holdings | Assumes: Buy | $200 | $9.54 | +1,996.44% | 7 | May 25, 2023 | |
| HOWL Werewolf Therapeutics | Assumes: Buy | $8.3 | $1.36 | +510.29% | 6 | May 25, 2023 | |
| REGN Regeneron Pharmaceuticals | Reiterates: Buy | $862 | $487.86 | +76.69% | 11 | May 1, 2023 | |
| EXEL Exelixis | Reiterates: Buy | $24 | $42.67 | -43.75% | 10 | Apr 28, 2023 | |
| AGEN Agenus | Reiterates: Buy | $166 | $5.00 | +3,220.00% | 8 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $9.14 | +359.52% | 5 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $304 | $303.77 | +0.08% | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $116 | $7.69 | +1,408.45% | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.14 | +381.31% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $30.94 | -22.43% | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,000 → $800 | $0.80 | +99,912.50% | 2 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $46 | $23.52 | +95.58% | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $96 | $33.37 | +187.68% | 6 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $0.68 | +5,226.23% | 1 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.30 | +3,835.72% | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $5.79 | +435.41% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $33 → $36 | $580.10 | -93.79% | 2 | Nov 13, 2017 | |
Apollomics
Apr 1, 2024
Maintains: Buy
Price Target: $1,100 → $650
Current: $6.47
Upside: +9,946.37%
Sonnet BioTherapeutics Holdings
Aug 23, 2023
Assumes: Buy
Price Target: $1,179
Current: $1.17
Upside: +100,936.76%
Lantern Pharma
Aug 10, 2023
Reiterates: Buy
Price Target: $11
Current: $3.27
Upside: +236.39%
Biomea Fusion
Jun 26, 2023
Reiterates: Buy
Price Target: $32
Current: $2.49
Upside: +1,185.14%
Jasper Therapeutics
Jun 12, 2023
Reiterates: Buy
Price Target: $69
Current: $5.90
Upside: +1,061.02%
Coeptis Therapeutics Holdings
May 25, 2023
Assumes: Buy
Price Target: $200
Current: $9.54
Upside: +1,996.44%
Werewolf Therapeutics
May 25, 2023
Assumes: Buy
Price Target: $8.3
Current: $1.36
Upside: +510.29%
Regeneron Pharmaceuticals
May 1, 2023
Reiterates: Buy
Price Target: $862
Current: $487.86
Upside: +76.69%
Exelixis
Apr 28, 2023
Reiterates: Buy
Price Target: $24
Current: $42.67
Upside: -43.75%
Agenus
Mar 28, 2023
Reiterates: Buy
Price Target: $166
Current: $5.00
Upside: +3,220.00%
Feb 24, 2023
Reiterates: Buy
Price Target: $42
Current: $9.14
Upside: +359.52%
Feb 24, 2023
Reiterates: Buy
Price Target: $304
Current: $303.77
Upside: +0.08%
Feb 24, 2023
Maintains: Buy
Price Target: $123 → $116
Current: $7.69
Upside: +1,408.45%
Dec 16, 2022
Initiates: Buy
Price Target: $10
Current: $2.14
Upside: +381.31%
Mar 23, 2022
Initiates: Buy
Price Target: $24
Current: $30.94
Upside: -22.43%
Mar 11, 2022
Maintains: Buy
Price Target: $1,000 → $800
Current: $0.80
Upside: +99,912.50%
Mar 8, 2022
Maintains: Buy
Price Target: $43 → $46
Current: $23.52
Upside: +95.58%
Mar 3, 2022
Maintains: Buy
Price Target: $98 → $96
Current: $33.37
Upside: +187.68%
Jan 10, 2022
Initiates: Buy
Price Target: $36
Current: $0.68
Upside: +5,226.23%
Dec 23, 2021
Initiates: Buy
Price Target: $12
Current: $0.30
Upside: +3,835.72%
Nov 5, 2021
Maintains: Buy
Price Target: $25 → $31
Current: $5.79
Upside: +435.41%
Nov 13, 2017
Maintains: Market Outperform
Price Target: $33 → $36
Current: $580.10
Upside: -93.79%